Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

229.48 +4.67 (+2.08%)
Official Closing Price Updated: 4:10 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,462,471
Open 225.82
Bid (Size) 227.07 (100)
Ask (Size) 229.90 (1,500)
Prev. Close 224.81
Today's Range 225.79 - 231.43
52wk Range 164.39 - 244.81
Shares Outstanding N/A
Dividend Yield 3.02%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Axsome Therapeutics (AXSM): A CNS Powerhouse at a Commercial Crossroad
As of February 23, 2026, the biotechnology landscape has shifted away from the speculative fervor of the early 2020s toward a demand for commercial execution and sustainable revenue. Standing at the... 
Via Finterra
Topics Economy Initial Public Offering Intellectual Property
News headline image
1 Cash-Producing Stock to Target This Week and 2 We Ignore
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory

Performance

YTD
+0.1%
+0.1%
1 Month
+4.7%
+4.7%
3 Month
-0.0%
-0.0%
6 Month
+10.6%
+10.6%
1 Year
+12.4%
+12.4%

More News

Read More
News headline image
3 Stocks to Buy and Hold for 2026 and Beyond ↗
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
2 Dividend Stocks to Hold for the Next 5 Years ↗
Via The Motley Fool
Topics Energy Intellectual Property
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
6 Forever Dividend Stocks ↗
Via The Motley Fool
News headline image
1 Mega-Cap Stock on Our Watchlist and 2 We Avoid
Via StockStory
News headline image
8 Cheap Stocks to Buy in 2026 ↗
Via The Motley Fool
News headline image
1 No-Brainer Dividend Stock to Buy on the Dip ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
5 Best Stocks to Buy in February ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Dividend Stocks to Hold for the Next 20 Years ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗
Via The Motley Fool
Topics Stocks
News headline image
Got $500? 2 Pharma Stocks to Buy and Hold Forever. ↗
Via The Motley Fool
News headline image
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
Via MarketMinute
Topics Artificial Intelligence ETFs Government
News headline image
The Great Rotation: Healthcare Emerges as the S&P 500’s New Crown Jewel in 2026
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
1 Reason I'm Never Selling AbbVie Stock ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
Via Finterra
Topics Economy Intellectual Property
News headline image
The 5 Most Interesting Analyst Questions From AbbVie’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
Silver and Gold Prices Are Volatile. Buy This ETF for Safety This Year ↗
Via The Motley Fool
Topics ETFs
News headline image
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
Via FinancialNewsMedia
News headline image
3 Market-Beating Stocks to Research Further
Via StockStory
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
AbbVie’s Prognosis: The February Dip Looks Like a Buy Signal ↗
Via MarketBeat
News headline image
ABBV Q4 Deep Dive: Immunology and Neuroscience Growth Offset Aesthetics Softness and Pricing Headwinds
Via StockStory
News headline image
AbbVie (ABBV) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 229.48
When was AbbVie last traded?
The last trade of AbbVie was at 02/23/26 04:10 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.